Cortical lesions in multiple sclerosis

Brain

Volumn 122, Issue 1, 1999, Pages 17-26

  Kidd, D ^a   Barkhof, F ^b   McConnell, R ^d   Algra, P R ^b   Allen, I V ^d   Revesz, Tamas ^a,c  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d NONE

Author keywords

Cortical lesions; MRI; Multiple sclerosis; Neuropathology

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; BRAIN CORTEX LESION; BRAIN VEIN; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; WHITE MATTER;

ADULT; CADAVER; CEREBRAL CORTEX; CEREBRAL VEINS; EVALUATION STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS;

EID: 0032935470     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/122.1.17     Document Type: Article

References (32)

1. Barkhof F. Filippi M, Miller DH, Scheltens P, Campi A, Polman CH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. [Review]. Brain 1997; 120: 2059-69.
2. Barnard RO, Triggs M. Corpus callosum in multiple sclerosis. J Neurol Neurosurg Psychiatry 1974; 37: 1259-64.
3. Beatty WW, Goodkin DE, Monson N, Beatty PA. Cognitive disturbances in patients with relapsing-remitting multiple sclerosis. Arch Neurol 1989; 46: 1113-9.
4. Brownell B, Hughes JT. The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry 1962; 25: 315-20.
5. Damian MS, Schilling G, Bachmann G, Simon C, Stoppler S, Dorndorf W. White matter lesions and cognitive deficits: relevance of lesion pattern? Acta Neurol Scand 1994; 90: 430-6.
6. Day TJ, Fisher AG, Mastaglia FL. Alexia with agraphia in multiple sclerosis. J Neurol Sci 1987; 78: 343-8.
7. De Reuck J. The cortico-subcortical arterial angio-architecture in the human brain. Acta Neurol Belg 1972; 72: 323-9.
8. Drake WE, MacKay D. Epilepsy in multiple sclerosis. Neurology 1961; 11: 810-6.
9. Duvernoy HM, Delon S, Vannson JL. Cortical blood vessels of the human brain. Brain Res Bull 1981; 7: 519-79.
10. Foong J, Rozewicz L, Quaghebeur G, Davie CA, Kartsounis LD, Thompson AJ, et al. Executive function in multiple sclerosis: the role of frontal lobe pathology. Brain 1997; 120: 15-26.
11. Franklin GM, Nelson LM, Filley CM, Heaton RK. Cognitive loss in multiple sclerosis; case reports and a review of the literature. [Review]. Arch Neurol 1989; 46: 162-7.
12. Ghezzi A, Montanini R, Basso PF, Zaffaroni M, Massimo E, Cazullo CL. Epilepsy in multiple sclerosis. Eur Neurol 1990; 30: 218-23.
13. Graham DI. Hypoxia and vascular disorders. In: Adams JH, Duchen LW, editors. Greenfield's neuropathology. 5th ed. London: Edward Arnold; 1992. p. 153-268.
14. Huber SJ, Paulson GW, Shuttleworth EC, Chakeres D, Clapp LE, Pakanis A, et al. Magnetic resonance imaging correlates of dementia in multiple sclerosis. Arch Neurol 1987; 44: 732-6.
15. Jacome DE. Palinopsia and bitemporal visual extinction on fixation. Ann Ophthalmol 1985; 17: 251-2.
16. Kahana E, Leibowitz U, Alter M. Cerebral multiple sclerosis. Neurology 1971; 21: 1179-85.
17. Kermode AG, Thompson AJ, Tofts P, MacManus DG, Kendall BE, Kingsley DP, et al. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. Brain 1990; 113: 1477-89.
18. Lumsden CE. The neuropathology of multipe sclerosis. In: Vinken PJ, Bruyn GW, editors. Handbook of clinical neurology, Vol. 9, Amsterdam: North-Holland; 1970. p. 217-309.
19. McAlpine D. Symptoms and signs. In: McAlpine D, Lumsden CE, Acheson ED. Multiple sclerosis: a reappraisal. 2nd ed. Edinburgh: Churchill Livingstone; 1972. p. 174-7.
20. Matthews WB. Epilepsy and disseminated sclerosis. Quart J Med 1962; 31: 141-55.
21. Matthews WB. Symptoms and signs. In: Matthews WB, Compston A, Allen IV, Martyn CN, editors. McAlpine's multiple sclerosis. 2nd ed. Edinburgh: Churchill Livingstone; 1991. p. 61-3.
22. Miller DH, Barkhof F, Nauta JJ. Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. Brain 1993; 116: 1077-94.
23. Nagano H, Inoue T, Koga T, Kitaguchi T, Tateishi J, Goto I. Formalin fixed brains are useful for magnetic resonance imaging (MRI). J Neurol Sci 1987; 81: 67-77.
24. Poser S. Multiple sclerosis: an analysis of 812 cases by means of electronic data processing. Berlin: Springer; 1978.
25. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
26. Pozzilli C, Bastianello S, Padovani A, Passafiume D. Millefiorini E, Bozzao L, et al. Anterior corpus callosum atrophy and verbal fluency in multiple sclerosis. Cortex 1991; 27; 441-5.
27. Rao SM, Leo GJ, Haughton VM, St. Aubin-Faubert P, Bernardin L. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 1989; 39: 161-6.
28. Revesz T, Kidd D, Thompson AJ, Barnard RO, McDonald WI. A comparison of the pathology of primary and secondary progressive multiple sclerosis. Brain 1994; 117: 759-65.
29. Ron MA, Callanan MM, Warrington EK. Cognitive abnormalities in multiple sclerosis: a psychometric and MRI study. Psychol Med 1991; 21: 59-68.
30. Rovaris M, Yousry T, Calori G, Fesl G, Voltz R, Filippi M. Sensitivity and reproducibility of fast - FLAIR, FSE, and TGSE sequences for the MRI assessment of brain lesion load in multiple sclerosis. A preliminary study. J Neuroimaging 1997; 7: 98-102.
31. Thompson AJ, Kermode AG, Moseley IF, MacManus DG, McDonald WI. Seizures due to multiple sclerosis: seven patients with MRI correlations. J Neurol Neurosurg Psychiatry 1993; 56: 1317-20.
32. Truyen L, Barkhof F, Frequin STFM, Polman CH, Tobi H, Hommes OR, et al. Magnetic resonance imaging of epilepsy in multiple sclerosis: a case control study. Implications for treatment trials with 4-aminopyridine. Multiple Sclerosis 1996; 1: 213-7.